prochlorperazine + folic acid

Prochlorperazine + folic acid is a combination of prochlorperazine, a first-generation phenothiazine antipsychotic, and folic acid, a synthetic form of folate (vitamin B9). Prochlorperazine acts primarily as a **dopamine D2 receptor antagonist** in the chemoreceptor trigger zone of the medulla, providing potent antiemetic effects for severe nausea and vomiting, while also treating schizophrenia and non-psychotic anxiety through blockade of central dopamine receptors; it exhibits additional antagonism at histaminergic H1, cholinergic muscarinic, and alpha-1 adrenergic receptors. Folic acid serves as a cofactor in one-carbon metabolism, supporting DNA synthesis, red blood cell production, and neural tube development, often included to mitigate potential folate depletion from prochlorperazine or for nutritional support. This pairing lacks a unique marketed brand and is not a standard FDA-approved fixed-dose product, potentially used in contexts like pregnancy-related hyperemesis where antiemetic therapy requires folate supplementation.